Terveystalo (TTALO.HE) Stock Analysis & AI Equity Report
Terveystalo (TTALO.HE) overview
Terveystalo (TTALO.HE) stock analysis and AI equity research. For the latest completed financial year, 2024, Terveystalo reported revenue of EUR 1,340m and operating profit of EUR 116m; the year-end share price was 10.52 EUR and market capitalisation was EUR 1,332m. Terveystalo is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Terveystalo's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-23. Data will be refreshed during report generation.
About Terveystalo
Terveystalo is Finland's largest private healthcare services provider and one of the leading occupational health providers in Finland and Sweden. It offers primary care, specialist care, diagnostics, day surgery, rehabilitation and digital appointments to corporate, insurance, consumer and public-sector customers through clinics, hospitals and the Feelgood subsidiary in Sweden.
Generate the Terveystalo report
Terveystalo is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Terveystalo and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.